Sanne de Bruin

20 Chapter 1 References 1. Bolton-Maggs PHB. SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents. Transfus Med . 2016;26(6):401-405. doi:10.1111/ tme.12380 2. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev . 2005;19(1):2-31. doi:10.1016/j.tmrv.2004.10.001 3. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): An update. Blood Rev . 2007;21(6):327-348. doi:10.1016/j.blre.2007.07.003 4. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood . 2012;119(7):1757-1767. doi:10.1182/blood-2011-08-370932 5. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion . 2002;42(7):812-818. doi:10.1046/ j.1537-2995.2002.00123.x 6. Shander A, Javidroozi M, Naqvi S, et al. An update onmortality andmorbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion . 2014;54(1):2688- 2695. doi:10.1111/trf.12565 7. Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev . 2016. doi:10.1002/14651858. CD002042.pub4 8. Holst LB, Haase N, Wetterslev J, et al. Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock. N Engl J Med . 2014;371(15):1381-1391. doi:10.1056/NEJMoa1406617 9. Rygård SL, Holst LB, Wetterslev J, et al. Long-termoutcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial. Intensive Care Med . 2016. doi:10.1007/s00134-016-4437-x 10. Carson JL, Sieber F, Cook DR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet . 2015;385(9974):1183- 1189. doi:10.1016/S0140-6736(14)62286-8 11. Brunskill SJ, Millette SL, Shokoohi A, et al. Red blood cell transfusion for people undergoing hip fracture surgery. Cochrane Database Syst Rev . 2015. doi:10.1002/14651858.CD009699.pub2 12. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med . 1999. doi:10.1056/NEJM199902113400601 13. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med . 2013;368:11-21. doi:10.1056/NEJMoa1211801 14. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood . 2014;123(18):2759-2767. doi:10.1182/blood-2013-11-462432 15. Vincent J-L, Jaschinski U, Wittebole X, et al. Worldwide audit of blood transfusion practice in critically ill patients. Crit Care . 2018;22(1):102. doi:10.1186/s13054-018-2018-9 16. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med . 2002;30(8):1765-1771. http://www.ncbi.nlm.nih.gov/pubmed/2163790.